- Home
- GRWG vs IKNA Comparison
GRWG vs IKNA Comparison
Compare GRWG & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRWG
- IKNA
- Stock Information
- Founded
- GRWG 2008
- IKNA 2016
- Country
- GRWG United States
- IKNA United States
- Employees
- GRWG N/A
- IKNA N/A
- Industry
- GRWG RETAIL: Building Materials
- IKNA Biotechnology: Pharmaceutical Preparations
- Sector
- GRWG Consumer Discretionary
- IKNA Health Care
- Exchange
- GRWG Nasdaq
- IKNA Nasdaq
- Market Cap
- GRWG 59.4M
- IKNA 63.7M
- IPO Year
- GRWG N/A
- IKNA 2021
- Fundamental
- Price
- GRWG $1.10
- IKNA $1.43
- Analyst Decision
- GRWG Buy
- IKNA Buy
- Analyst Count
- GRWG 4
- IKNA 2
- Target Price
- GRWG $2.38
- IKNA $13.50
- AVG Volume (30 Days)
- GRWG 856.9K
- IKNA 434.6K
- Earning Date
- GRWG 08-07-2025
- IKNA 07-24-2025
- Dividend Yield
- GRWG N/A
- IKNA N/A
- EPS Growth
- GRWG N/A
- IKNA N/A
- EPS
- GRWG N/A
- IKNA N/A
- Revenue
- GRWG $176,681,000.00
- IKNA N/A
- Revenue This Year
- GRWG N/A
- IKNA N/A
- Revenue Next Year
- GRWG N/A
- IKNA N/A
- P/E Ratio
- GRWG N/A
- IKNA N/A
- Revenue Growth
- GRWG N/A
- IKNA N/A
- 52 Week Low
- GRWG $0.82
- IKNA $0.97
- 52 Week High
- GRWG $2.47
- IKNA $1.94
- Technical
- Relative Strength Index (RSI)
- GRWG 53.70
- IKNA 59.83
- Support Level
- GRWG $0.96
- IKNA $1.20
- Resistance Level
- GRWG $1.21
- IKNA $1.42
- Average True Range (ATR)
- GRWG 0.06
- IKNA 0.08
- MACD
- GRWG 0.02
- IKNA 0.00
- Stochastic Oscillator
- GRWG 56.00
- IKNA 82.26
About GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.